(Q21135251)

17 August 2022

Qun-Fei Chen

series ordinal

2

author given names

Qun-Fei

author last names

Chen

1 reference

17 August 2022

You-Ping Li

series ordinal

3

author given names

You-Ping

author last names

Li

1 reference

17 August 2022

Si-Miao Wu

series ordinal

4

author given names

Si-Miao

author last names

Wu

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

9

0 references

page(s)

e23826

0 references

copyright license

start time

6 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

The mystery of the mycobacterial 'persistor'

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023826

Mycobacterium vaccae immunotherapy for treating tuberculosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0023826

[A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis]

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3167806

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease

29 November 2018

1 reference

12 December 2020

Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group

1 reference

12 December 2020

Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172)

1 reference

12 December 2020

[The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis]

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0023826

Identifiers

DOI

1 reference

ADS bibcode

2011PLoSO...623826Y

0 references

1 reference

1 reference

1 reference